Zydus Wellness Ltd
NSE:ZYDUSWELL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zydus Wellness Ltd
Intangible Assets
Zydus Wellness Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Zydus Wellness Ltd
NSE:ZYDUSWELL
|
Intangible Assets
₹33B
|
CAGR 3-Years
82%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Tata Consumer Products Ltd
NSE:TATACONSUM
|
Intangible Assets
₹72.4B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Britannia Industries Ltd
NSE:BRITANNIA
|
Intangible Assets
₹62.2m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Patanjali Foods Ltd
NSE:PATANJALI
|
Intangible Assets
₹15.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Marico Ltd
NSE:MARICO
|
Intangible Assets
₹9.5B
|
CAGR 3-Years
22%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Nestle India Ltd
NSE:NESTLEIND
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Wellness Ltd
Glance View
Zydus Wellness Ltd. weaves its narrative by fusing health-conscious innovation with strategic market positioning. Originating as an offshoot of the pharmaceutical giant Cadila Healthcare, Zydus Wellness was established to harness the rising tide of the wellness revolution in India. At the heart of its portfolio are brands like Sugar Free, Everyuth, and Nutralite, each carefully cultivated to address specific consumer demands for healthier lifestyle choices. Sugar Free, a leader in the artificial sweetener space, capitalizes on the growing diabetic and diet-conscious population, while Everyuth's exfoliating and skincare ranges tap into beauty and personal care. Meanwhile, Nutralite tackles the shift towards healthier dietary options with its line of cholesterol-free butter alternatives. This diverse portfolio highlights Zydus Wellness’s grasp of consumer insights and its ability to align product innovation with societal trends. The company’s financial tapestry is woven from the threads of brand loyalty and expansive distribution channels. Its approach deftly combines strong marketing strategies with a robust distribution framework, ensuring that its products readily reach varied consumer bases across urban and rural landscapes. Zydus Wellness leverages its relationship with Zydus Cadila to benefit from shared resources and synergies in research and development, enhancing its capacity for product refinement and innovation. This symbiotic relationship strengthens its market presence and supports its financial growth. By effectively managing its brand portfolio and continuously expanding its market reach, Zydus Wellness not only sustains its revenue streams but also solidifies its standing in the competitive wellness segment. Through strategic foresight and customer-centric product evolution, Zydus Wellness navigates the dynamic landscape, thriving amidst the increasing consumer gravitation towards healthier alternatives.
See Also
What is Zydus Wellness Ltd's Intangible Assets?
Intangible Assets
33B
INR
Based on the financial report for Dec 31, 2025, Zydus Wellness Ltd's Intangible Assets amounts to 33B INR.
What is Zydus Wellness Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
43%
Over the last year, the Intangible Assets growth was 511%. The average annual Intangible Assets growth rates for Zydus Wellness Ltd have been 82% over the past three years , 43% over the past five years .